Picterus has developed a smartphone application that can screen for neonatal jaundice with high accuracy.
Picterus's investors include European Innovation Council, EIC Accelerator, EISMEA, CVX Ventures, Farvatn Venture.
Picterus is headquartered in Trondheim, Norway.
Picterus has developed a smartphone application that can screen for neonatal jaundice with high accuracy.
Picterus is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Picterus — Funding & Investors." VCBacked, June 19, 2023, https://www.vcbacked.co/company/picterus. Accessed September 30, 2026.
VCBacked. (2023). Picterus — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/picterus
{{cite web |title=Picterus — Funding & Investors |url=https://www.vcbacked.co/company/picterus |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated